Skip to content

Author

Scott D. Solomon

7 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

High-dose vs standard-dose influenza vaccine in older adults according to diabetes status, a prespecified analysis of the FLUNITY-HD study

The FLUNITY-HD study, pooled analysis including 466,320 randomized older adults, demonstrated that high-dose inactivated influenza vaccine (HD-IIV) provided proven superior protection against hospitalization outcomes than standard-dose inactivated influenza vaccine (SD-IIV) among adults aged ≥65 years. Whether th...

K. Hosseini, N. Johansen, D. Modin et al. · 0 citations
Open access Aug 2026

Predictors of echocardiographic response in the Budapest-CRT upgrade trial.

BACKGROUND AND AIMS Up to 30% of patients fail to respond after cardiac resynchronization therapy (CRT). While echocardiographic predictors of response are well described in de novo CRT, evidence in CRT upgrade populations remains limited. We investigated predictors of echocardiographic response in the BUDAPEST-CRT Upg...

E. Merkel, R. Masszi, B. Lakatos et al. · 0 citations
Aug 2026

Bivalent RSV Prefusion F Vaccine to Prevent Hospitalizations in Adults.

BACKGROUND Respiratory syncytial virus (RSV) is an important cause of severe respiratory disease in adults, with the highest burden among older adults and individuals with chronic health conditions. The bivalent RSV prefusion F (RSVpreF) vaccine has been shown to prevent RSV-associated respiratory illness, but data fro...

M. Lassen, S. Christensen, M. Yafasov et al. · 1 citation
Open access 2027

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty...

C. Espersen, N. Johansen, D. Modin et al. · 0 citations
#protein folding Open access Oct 2026

RSV prefusion F vaccine effectiveness in older adults with immunosuppression: a prespecified analysis of the DAN-RSV trial.

In adults aged 60 years or older, RSVpreF vaccination reduced hospitalisations for RSV-related respiratory tract disease with no statistical evidence of effect modification by immunosuppression status; however, the study was not powered to exclude subgroup differences.

A. Reimer Jensen, M. H. Højbjerg Lassen, N. Johansen et al. · 0 citations
Open access Sep 2026

Native T1 for Diagnosis and Risk Prediction in Amyloid Transthyretin Cardiomyopathy: An Observational Study on 1,675 Subjects.

BACKGROUND Native T1 mapping is a contrast-free cardiac magnetic resonance (CMR) marker of myocardial amyloid infiltration, but center-specific diagnostic cutoffs and prognostic strata remain incompletely defined across transthyretin amyloidosis (ATTR). OBJECTIVES This study aims to define native T1 thresholds and ri...

Alberto Aimo, A. Sheikh, Sorayya Kakhi et al. · 0 citations
Oct 2026

Pharmacological treatment strategies to prevent heart failure across the cardiovascular-kidney-metabolic spectrum: an EJHF Expert Consensus Statement.

Heart failure (HF) remains a major cause of morbidity, mortality, and increased healthcare costs worldwide, and is recognized as the result of progressive cardiovascular-kidney-metabolic (CKM) syndrome. Obesity, type 2 diabetes, chronic kidney disease, hypertension, and atherosclerotic cardiovascular disease frequently...

R. Inciardi, A. Abdin, M. Abdelhamid et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.